Aktis Oncology (AKTS) director sells 4,856 shares after exercising options
Rhea-AI Filing Summary
Aktis Oncology director Ken Herrmann exercised vested stock options and sold the resulting shares on July 20, 2026. He exercised options for 3,506 shares at $0.08 per share and 1,350 shares at $1.91 per share, acquiring 4,856 common shares. He then sold 4,856 common shares at a weighted average price of $24.5622 per share in transactions priced between $24.50 and $24.66.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 4,856 shares ($116K approx. pre-tax spread)
Exercise and Sale
6 txns
Insider
Herrmann Ken
Role
Director
Sold
4,856 shs ($119K)
Approx. gross sale proceeds
$119K
Approx. exercise cost
$3K
Approx. pre-tax spread
$116K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F2 | 3,506 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F2 | 1,350 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,506 | $0.08 | $280.48 |
| Exercise | Common Stock | 1,350 | $1.91 | $3K |
| Sale | Common Stock F1 | 3,506 | $24.5622 | $86K |
| Sale | Common Stock F1 | 1,350 | $24.5622 | $33K |
Holdings After Transaction:
Stock Option (Right to Buy) — 18,364 shares (Direct);
Common Stock — 0 shares (Direct)
Footnotes (2)
- F1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.50 to $24.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F2. These options have vested in full.
Key Figures
Shares sold: 4,856 shares
Weighted average sale price: $24.5622 per share
Options exercised at $0.08: 3,506 shares
+2 more
5 metrics
Shares sold
4,856 shares
Common stock sold by director on July 20, 2026
Weighted average sale price
$24.5622 per share
Sales of common stock at prices from $24.50 to $24.66
Options exercised at $0.08
3,506 shares
Stock options exercised at $0.08 per share into common stock
Options exercised at $1.91
1,350 shares
Stock options exercised at $1.91 per share into common stock
Total shares from option exercises
4,856 shares
Common shares acquired via option exercises before sale
Key Terms
Stock Option (Right to Buy), weighted average price, derivative security, Common Stock
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What transactions did Ken Herrmann report for Aktis Oncology (AKTS)?
Ken Herrmann exercised stock options for 4,856 shares of Aktis Oncology common stock and then sold all 4,856 shares on July 20, 2026, in market transactions at a weighted average sale price of $24.5622 per share.
What stock options did Herrmann exercise in this AKTS insider transaction?
Herrmann exercised options covering 3,506 shares at $0.08 per share and 1,350 shares at $1.91 per share. These vested stock options converted into 4,856 shares of common stock, which were then sold the same day at market prices.
Were the Aktis Oncology (AKTS) stock options fully vested when exercised?
Yes. A footnote states that these options had vested in full at the time of exercise. That means the options were fully earned and exercisable when Herrmann converted them into common shares before selling those shares.
Was Herrmann’s AKTS trade under a Rule 10b5-1 trading plan?
No. These transactions are not designated as taking place under a Rule 10b5-1 trading plan, indicating they are reported as discretionary insider trades rather than trades executed pursuant to a pre-arranged trading plan.